The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), has announced Eric M. Verdin, MD, as the winner of the Avant-Garde Award for HIV/AIDS Research, according to an NIH statement. Verdin’s research will focus on developing new technology to explain how HIV latency is established and maintained and how it becomes reactivated. The goal is to eliminate latent HIV infection. The award grants Verdin, of the J. David Gladstone Institutes in San Francisco, $500,000 per year for five years.

To read the NIH statement, click here.